Food and Drug Administration

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

Today, the FDA is alerting the public that several categories of FDA-regulated products purchased from Family Dollar stores in Alabama, Arkansas, Louisiana, Mississippi, Missouri and Tennessee may be unsafe for consumers to use.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA, along with the CDC and our state and local partners, is investigating complaints of Cronobacter and Salmonella illnesses related to Similac powdered infant formula.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA issued an emergency use authorization for a new monoclonal antibody for the treatment of COVID-19 that retains activity against the omicron variant.

The FDA is postponing the Feb. 15 Vaccines and Related Biological Products Advisory Committee meeting given new data that have recently emerged regarding Pfizer’s emergency use authorization request for the use of the Pfizer-BioNTech COVID-19 Vaccine in children 6 months through 4 years of age.

The U.S Food and Drug Administration issued a draft guidance to provide recommendations to companies developing non-opioid analgesics for acute pain lasting up to 30 days, typically in response to some form of tissue injury, such as trauma or surgery.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

FDA Sodium Reduction Efforts Underscored in USDA’s Transitional Nutrition Standards for School Meals

The U.S. Food and Drug Administration today approved an application for the first generic of Restasis (cyclosporine ophthalmic emulsion) eye drops to increase tear production.

The U.S. Food and Drug Administration today approved an application for the first generic of Restasis (cyclosporine ophthalmic emulsion) eye drops to increase tear production.

FDA announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee on Feb. 15 to discuss the request for emergency use authorization of the Pfizer-BioNTech COVID-19 Vaccine for use in children 6 months through 4 years of age.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The FDA approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.

The U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency.